Ortec gets delisting warning from Nasdaq:
This article was originally published in Clinica
Tissue engineering company Ortec International has received a Nasdaq delisting warning, after the New York-based company's listed securities fell below the required market value of $35m. The company has requested a hearing before a Nasdaq listing qualifications panel. At the same time, Ortec is working on a plan aimed at ensuring that it meets the listing requirements.